Seer/$SEER
1D1W1MYTD1Y5YMAX
About Seer
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
- Ticker
- $SEER
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 124
- Headquarters
- Redwood City, United States
- Website
- seer.bio
Seer Metrics
BasicAdvanced
$110M
-
-$1.22
1.52
-
Price and volume
Market cap
$110M
Beta
1.52
52-week high
$2.41
52-week low
$1.55
Average daily volume
710K
Financial strength
Current ratio
14.742
Quick ratio
13.871
Long term debt to equity
8.719
Total debt to equity
9.921
Profitability
EBITDA (TTM)
-64.85
Gross margin (TTM)
47.70%
Net profit margin (TTM)
-478.05%
Operating margin (TTM)
-498.19%
Effective tax rate (TTM)
-0.10%
Revenue per employee (TTM)
$110,000
Management effectiveness
Return on assets (TTM)
-15.29%
Return on equity (TTM)
-26.45%
Valuation
Price to revenue (TTM)
7.78
Price to book
0.49
Price to tangible book (TTM)
0.49
Price to free cash flow (TTM)
-2.501
Free cash flow yield (TTM)
-39.99%
Free cash flow per share (TTM)
-0.792
Growth
Revenue change (TTM)
-12.71%
Earnings per share change (TTM)
-12.30%
3-year revenue growth (CAGR)
-5.07%
3-year earnings per share growth (CAGR)
-6.46%
What the Analysts think about Seer
Analyst ratings (Buy, Hold, Sell) for Seer stock.
Seer Financial Performance
Revenues and expenses
Seer Earnings Performance
Company profitability
Seer News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.